These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 719130)

  • 21. Pharmacokinetics of human activated protein C. 1st communication: plasma concentration and excretion of a lyophilized purified human activated protein C after intravenous administration in the mouse and the rabbit.
    Ishii S; Mochizuki T; Nagao T; Sugiki S; Kudo S; Harakawa N; Taniguchi K; Igarashi Y; Kondo S; Kiyoki M
    Arzneimittelforschung; 1995 May; 45(5):636-44. PubMed ID: 7612068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leukemic cell versus plasma levels of daunorubicin and daunorubicinol after infusion of daunorubicin as free drug or the DNA complex.
    Andersson B; Beran M
    Cancer Chemother Pharmacol; 1980; 4(3):205-7. PubMed ID: 7397945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uptake and distribution of daunorubicin and daunorubicin-DNA complex in mice as studied by whole-body autoradiography and liquid chromatography.
    Andersson B; Beran M; Eberhardsson B; Eksborg S; Slanina P
    Cancer Chemother Pharmacol; 1979; 2(3):159-67. PubMed ID: 110487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human pharmacokinetics of the daunorubicin-DNA complex. An alternative view of the lysosomotropic theory.
    Hulhoven R; Sokal G; Harvengt C
    Cancer Chemother Pharmacol; 1979; 3(4):243-7. PubMed ID: 535134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative metabolism of daunorubicin and 4-demethoxydaunorubicin in mice and rabbits.
    Broggini M; Sommacampagna B; Paolini A; Dolfini E; Donelli MG
    Cancer Treat Rep; 1986 Jun; 70(6):697-702. PubMed ID: 3524823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of cellular pharmacokinetics for the cytotoxic effects of daunorubicin.
    Andersson B; Beran M; Peterson C; Tribukait B
    Cancer Res; 1982 Jan; 42(1):178-83. PubMed ID: 7053847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of pharmacokinetics of M1, M2, M3, and M4 after intravenous administration of DA-125 or ME2303 to mice and rats. New adriamycin analogues containing fluorine.
    Yoon EJ; Lee WI; Shim HJ; Lee SD; Kim WB; Yang J; Lee MG
    Biopharm Drug Dispos; 1996 Jul; 17(5):373-420. PubMed ID: 8830976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoreactivity and pharmacokinetics of horse anti-scorpion venom F(ab')2-scorpion venom interactions.
    Pépin-Covatta S; Lutsch C; Grandgeorge M; Lang J; Scherrmann JM
    Toxicol Appl Pharmacol; 1996 Nov; 141(1):272-7. PubMed ID: 8917700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase I and clinical pharmacology studies of intravenous and oral administration of 4-demethoxydaunorubicin in patients with advanced cancer.
    Berman E; Wittes RE; Leyland-Jones B; Casper ES; Gralla RJ; Howard J; Williams L; Baratz R; Young CW
    Cancer Res; 1983 Dec; 43(12 Pt 1):6096-101. PubMed ID: 6580068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High concentration of Daunorubicin and Daunorubicinol in human malignant astrocytomas after systemic administration of liposomal Daunorubicin.
    Albrecht KW; de Witt Hamer PC; Leenstra S; Bakker PJ; Beijnen JH; Troost D; Kaaijk P; Bosch AD
    J Neurooncol; 2001 Jul; 53(3):267-71. PubMed ID: 11718259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantification of daunorubicin and daunorubicinol in plasma by capillary electrophoresis.
    Hempel G; Schulze-Westhoff P; Flege S; Boos J
    J Chromatogr B Biomed Sci Appl; 2001 Jul; 758(2):221-8. PubMed ID: 11486832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The seminal excretion, plasma elimination, tissue distribution and metabolism of naltrexone in the rabbit.
    Taylor SM; Rodgers RM; Lynn RK; Gerber N
    J Pharmacol Exp Ther; 1980 May; 213(2):289-99. PubMed ID: 7365688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Daunorubicin-induced cardiac injury in the rabbit: a role for daunorubicinol?
    Cusack BJ; Mushlin PS; Voulelis LD; Li X; Boucek RJ; Olson RD
    Toxicol Appl Pharmacol; 1993 Feb; 118(2):177-85. PubMed ID: 8441996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolism of the anthracycline antibiotic daunorubicin to daunorubicinol and deoxydaunorubicinol aglycone in hepatocytes isolated from the rat and the rabbit.
    Gewirtz DA; Yanovich S
    Biochem Pharmacol; 1986 Nov; 35(22):4059-64. PubMed ID: 3778526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of daunorubicin and its main metabolites in plasma, urine and leukaemic cells in patients with acute myeloblastic leukaemia.
    Paul C; Baurain R; Gahrton G; Peterson C
    Cancer Lett; 1980 Jun; 9(4):263-9. PubMed ID: 6930988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of G3139, a phosphorothioate oligodeoxynucleotide antisense to bcl-2, after intravenous administration or continuous subcutaneous infusion to mice.
    Raynaud FI; Orr RM; Goddard PM; Lacey HA; Lancashire H; Judson IR; Beck T; Bryan B; Cotter FE
    J Pharmacol Exp Ther; 1997 Apr; 281(1):420-7. PubMed ID: 9103525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transscleral Coulomb-controlled iontophoresis of methylprednisolone into the rabbit eye: influence of duration of treatment, current intensity and drug concentration on ocular tissue and fluid levels.
    Behar-Cohen FF; El Aouni A; Gautier S; David G; Davis J; Chapon P; Parel JM
    Exp Eye Res; 2002 Jan; 74(1):51-9. PubMed ID: 11878818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in the plasma kinetics of daunorubicin in normal and leukemic rats.
    Andersson B; Beran M; Alván G; Peterson C
    Acta Radiol Oncol; 1981; 20(5):325-8. PubMed ID: 6278852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous administration of prostacyclin in rabbits: elimination kinetics and blood pressure response.
    Skrinska VA; Lucas FV; Chisolm GM; Hesse BL
    J Lab Clin Med; 1986 Mar; 107(3):187-93. PubMed ID: 3512745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Daunomycin and daunomycinol plasma levels measured by HPLC after perfusions of daunomycin and daunomycin-DNA complex in rabbits: a preliminary report.
    Hulhoven R; Desager JP; Sokal G; Harvengt C
    Arch Int Pharmacodyn Ther; 1977 Apr; 226(2):344-5. PubMed ID: 879917
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.